Affordable Access

The use of isotopes in the determination of absolute bioavailability of drugs in humans

Authors
Publisher
Informa Healthcare
Publication Date
Disciplines
  • Design
  • Medicine
  • Pharmacology

Abstract

Absolute bioavailability studies in humans are not routinely performed as part of the drug registration process. They tend to be reasonably demanding, not least because toxicology data are required to support intravenous administration of a drug. Moreover, the classical crossover design of an absolute bioavailability study can suffer from artefacts caused by concentration-dependent pharmacokinetics. Many of the problems associated with absolute bioavailability studies can be alleviated using isotopically labelled drugs. Stable isotopes have been used in the performance of absolute bioavailability studies in humans for > 30 years. More recently, the advantages of using radiolabelled drugs have been expanded by using the ultrasensitive technology of accelerator mass spectrometry. Isotopic labelling not only allows for the accurate and efficient determination of absolute bioavailability, but can also provide information on first-pass effects and other pharmacokinetic parameters. © 2006 Informa UK Ltd.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

The use of isotopes in the determination of absolu...

on Expert opinion on drug metabol... June 2006

Use of enriched stable isotopes to determine bioav...

on The Science of The Total Envir... June 1983

Use of enriched stable isotopes to determine bioav...

on The Science of The Total Envir... Jan 01, 1983

Absolute bioavailability of bromfenac in humans.

on The Annals of Pharmacotherapy April 1997
More articles like this..